Jonathan Ayers compensation by year
IDEXX Laboratories Summary Compensation Table · all 4 fiscal years held| Component | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Salary | $800,000 | $800,000 | $800,000 | $692,308 |
| Bonus | $0 | $0 | $0 | $0 |
| Stock awards | $0 | $0 | $0 | $0 |
| Option awards | $3,497,863 | $4,493,126 | $4,795,888 | $4,998,579 |
| Non-equity incentive | $1,545,000 | $1,350,000 | $1,200,000 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 |
| All other | $20,818 | $22,225 | $24,062 | $2,497,877 |
| Total | $5,863,681 | $6,665,351 | $6,819,950 | $8,188,764 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: IDEXX Laboratories Inc DEF 14A filed March 26, 2020, accession 0000874716-20-000013, and prior-year filings. Open the filing on EDGAR.
How this page was built: the IDEXX Laboratories Inc filed document, accession 0000874716-20-000013. Every figure is read from that document and cited to the page and table it appears in. Filed March 26, 2020.
Equity holdings
unvested awards at FY2019 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 66,549 | — | $141.60 |
| Option | 73,100 | — | $178.26 |
| Option | 79,772 | — | $67.85 |
| Option | 78,653 | — | $206.94 |
| Option | 29,976 | — | $79.54 |
Per the Outstanding Equity Awards at Fiscal Year-End table in IDEXX Laboratories Inc's FY2019 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
52 Form 4 lines since the FY2019 proxy (filed March 26, 2020)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2024-09-06 | Gift | — | 302,179 | $0.00 | 0 |
| 2024-09-06 | Gift | — | 112,605 | $0.00 | 122,605 |
| 2024-09-06 | Gift | — | 230,000 | $0.00 | 35,651 |
| 2024-09-06 | Gift | — | 419,574 | $0.00 | 419,574 |
| 2024-05-06 | Exercise or conversion derivative | — | 257 | $0.00 | 0 |
| 2024-05-06 | Exercise or conversion | — | 257 | $0.00 | 265,651 |
| 2024-02-09 | Gift | — | 5,350 | $0.00 | 265,394 |
| 2024-02-08 | Gift | — | 850 | $0.00 | 270,744 |
The 8 most recent of 52 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
IDEXX Laboratories’s named executive officers, FY2019
as the company reported each| Named executive officer | Role | FY2019 total |
|---|---|---|
| Jonathan Ayers · this page | Former Board Chair, President and Chief Executive Officer | $8,188,764 |
| Jonathan Mazelsky | President and Chief Executive Officer | $7,419,335 |
| Brian McKeon | Executive Vice President, Chief Financial Officer and Treasurer | $3,940,306 |
| Kathy Turner | Corporate Vice President and Chief Marketing Officer | $2,696,822 |
| Sharon Underberg | Corporate Vice President, General Counsel and Corporate Secretary | $1,809,228 |
| Michael Lane | Executive Vice President and General Manager, Reference Laboratories and Information Technology | $1,473,880 |
Board service
IDEXX Laboratories board · FY2021–FY2024| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2024 | $90,000 | $124,940 | $124,936 | $0 | $339,876 |
| FY2023 | $85,000 | $125,190 | $124,971 | $0 | $335,161 |
| FY2022 | $80,000 | $114,862 | $114,968 | $0 | $309,830 |
| FY2021 | $80,000 | $114,757 | $114,937 | $132,261 | $441,955 |
Each year as the company reported it in IDEXX Laboratories's director compensation table. Totals are the company's own disclosed totals.
How this board is paid
Company policy: IDEXX Laboratories pays directors a $90,000 cash retainer and $250,000 in RSUs/Options. As stated in IDEXX Laboratories's FY2024 proxy.
The full IDEXX Laboratories compensation record
free company briefThis page is one person within IDEXX Laboratories's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the IDEXX Laboratories proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are IDEXX Laboratories's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.